
Pharmacally
Cell therapy
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Cell therapy
Mergers & AcquisitionsSernova and Seraxis Close $11.2 Million Financing to Advance BetaNova’s Type 1 Diabetes Cell Therapy ProgramsSernova and Seraxis have closed an $11.2 million financing to advance SR-02, an allogeneic stem cell-derived pancreatic islet cell therapy for type 1 diabetes, with Phase 1/2 dosing…Fact-Checked
Mergers & AcquisitionsMesoblast Expands Its Cell Therapy Territory with CAR-Powered Precision PlatformMesoblast has licensed a CAR-engineered MSC platform to improve tissue targeting and potency, with applications in inflammatory bowel disease and lupus nephritis.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.